Asthma
From the Journals
Benralizumab maintains effectiveness in severe asthma at 2 years
The 2-year data from phase 3 trials confirm benefit.
From the Journals
Secondhand vaping aerosols linked to childhood asthma exacerbations
Exposure to vaping aerosols may have a role in triggering asthma attacks in children.
Opinion
The powerful virus inflammatory response
News
Two-thirds of COPD patients not using inhalers correctly
Nebulizer devices may be a better consideration for some patients.
Conference Coverage
Dupilumab offers extra benefits to asthmatic teens
Dupilumab, a fully human anti–IL-4Ra monoclonal antibody, resulted in lower rates of severe asthma exacerbation.
Conference Coverage
COPD: Triple trumps dual therapy regardless of baseline reversibility
SAN ANTONIO – Triple therapy reduced time to first moderate/severe COPD exacerbation when compared with dual therapy.
Conference Coverage
Reducing asthma, COPD exacerbations in obese patients
SAN ANTONIO - Obese patients with asthma or COPD typically have metabolic and inflammatory profiles that differ from those of nonobese patients...
Conference Coverage
Global bronchial thermoplasty registry for asthma documents benefits
A global registry showed that an improvement in quality of life 1 year after bronchothermoplasty was accompanied by reductions in exacerbations....
Conference Coverage
Dupilumab efficacy extends to chronic rhinosinusitis/nasal polyposis
PARIS – Post hoc analysis of phase 3 trial data looked at the efficacy dupilumab in preventing asthma exacerbations in patients with chronic...
From the Journals
Community-based therapy improved asthma outcomes in African American teens
A home- and community-based, individualized behavioral treatment significantly improved outcomes in African American teens with poorly controlled...
From the Journals
New guidance offered for managing poorly controlled asthma in children
A practical resource for starting or adjusting controller therapy in children with poorly-controlled asthma now is available.